Sumitovant Security Rating

At Sumitovant, we believe that the only way to develop therapies that have the potential to improve patient outcomes is to improve the drug candidate selection and drug development process. Curiosity, inquisitiveness and an innate spirit of thinking differently about the challenges to effective drug development are at the core of who we are and what we do. And patients are the reason why we do it. Combined with a passionate team that strives to improve patient outcomes, we are also leveraging our unparalleled DrugOME™ technology and Digital Innovation™ platform to ask and answer critical questions that reduce development timelines and costs, reduce uncertainty and enable us to build and advance a diverse portfolio of transformative therapies across many indications, including cancer, reproductive health, pulmonary and urologic diseases and rare and ultra-rare disorders.